TransMedics Group, Inc. (TMDX) PEG Ratio: 0.05
Is TransMedics Group, Inc.’s PEG ratio high or low?
TransMedics Group, Inc.'s PEG ratio of 0.05 is 96% below its 5-year average of 1.33, near the low end of its 5-year range (0.05–2.74).
TMDX PEG Ratio Chart
TMDX Average PEG Ratio Chart
TMDX Current vs Average PEG Ratio Chart
TMDX PEG Ratio Metrics
PEG RATIO
0.05
PEG RATIO AVG TTM
N/A
PEG RATIO AVG 3Y
1.66
PEG RATIO AVG 5Y
1.33
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-96.98%
CURRENT VS 5Y AVG
-96.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TMDX Competitors' PEG Ratio
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.72B | 0.05 | N/A | 1.66 | 1.33 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | N/A | 0.12 | 0.27 | 0.50 |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | 0.00 | 0.00 | 0.30 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | N/A | 0.10 | 0.17 | 0.14 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | N/A | 0.83 | 0.68 | 0.68 |
| Tempus AI, Inc. (TEM)vs › | $8.87B | N/A | 0.61 | 1.49 | 1.49 |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | N/A | 0.04 | 0.51 | 2.58 |
| Baxter International Inc. (BAX)vs › | $10.27B | N/A | 0.18 | 0.70 | 1.43 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | N/A | 0.05 | 0.05 | 0.14 |
| Revvity, Inc. (RVTY)vs › | $11.16B | 216.45 | 0.95 | 0.69 | 0.60 |
Growth-Adjusted Valuation
PEG Ratio
0.05
P/E Ratio
18.0
TransMedics Group, Inc. PEG Ratio Formula & Definition
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
TransMedics Group, Inc. PEG Ratio FAQ
- What is the PEG ratio for TransMedics Group, Inc. (TMDX)?
- The PEG ratio for TMDX stock is 0.05.
- Is TransMedics Group, Inc.'s PEG ratio high or low?
- TransMedics Group, Inc.'s PEG ratio of 0.05 is 96% below its 5-year average of 1.33, near the low end of its 5-year range (0.05–2.74).
- What is the 3Y average PEG ratio for TransMedics Group, Inc. (TMDX)?
- The 3Y average PEG ratio for TMDX stock is 1.66.
- What is the 5Y average PEG ratio for TransMedics Group, Inc. (TMDX)?
- The 5Y average PEG ratio for TMDX stock is 1.33.
TransMedics Group, Inc. PEG Ratio History
| DATE | PEG RATIO |
|---|---|
| 2025-12-31 | 0.05 |
| 2023-12-31 | 2.74 |
| 2022-12-31 | 2.18 |
| 2020-12-31 | 0.34 |
| 2018-12-31 | 1.24 |
| 2017-12-31 | 1.17 |
Related Metrics
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Waleed H. Hassanein